Biblio
Export 163 results:
[ Author
Filters: First Letter Of Last Name is H [Clear All Filters]
“Early Detection of Alzheimer's Disease Based on the Patient's Creative Drawing Process: First Results with a Novel Neuropsychological Testing Method.”, J Alzheimers Dis, vol. 63, no. 2, pp. 675-687, 2018.
, “Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 2, pp. 519-530, 2017.
, “Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.”, J Alzheimers Dis, vol. 51, no. 2, pp. 545-61, 2016.
, “Late-Life Depressive Symptoms and Lifetime History of Major Depression: Cognitive Deficits are Largely Due to Incipient Dementia rather than Depression.”, J Alzheimers Dis, vol. 54, no. 1, pp. 185-99, 2016.
, “Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1469-1478, 2019.
, “Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.”, J Alzheimers Dis, 2015.
, “New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy.”, J Alzheimers Dis, vol. 64, no. s1, pp. S529-S534, 2018.
, “Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1425-1440, 2024.
, “Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau.”, J Alzheimers Dis, vol. 53, no. 1, pp. 1-14, 2016.
, “Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1065-80, 2016.
, “Cardiovascular Response to Mental Stress in Mild Cognitive Impairment and its Association with Cerebral Perfusion.”, J Alzheimers Dis, 2018.
, “Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis.”, J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
, “Potentially Pathogenic Calcium Oxalate Dihydrate and Titanium Dioxide Crystals in the Alzheimer's Disease Entorhinal Cortex.”, J Alzheimers Dis, vol. 77, no. 2, pp. 547-550, 2020.
, “Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1133-1141, 2018.
, “Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 529-38, 2016.
, “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
, “Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1459-1467, 2018.
, “A 24-Week Multi-Modality Exercise Program Improves Executive Control in Older Adults with a Self-Reported Cognitive Complaint: Evidence from the Antisaccade Task.”, J Alzheimers Dis, vol. 56, no. 1, pp. 167-183, 2017.
, “A Six-Month Cognitive-Motor and Aerobic Exercise Program Improves Executive Function in Persons with an Objective Cognitive Impairment: A Pilot Investigation Using the Antisaccade Task.”, J Alzheimers Dis, vol. 54, no. 3, pp. 923-931, 2016.
, “Impact of the MIND Diet on Cognition in Individuals with Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 967-977, 2023.
, “Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.”, Arch Neurol, vol. 69, no. 5, pp. 636-43, 2012.
, “Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.”, J Alzheimers Dis, vol. 73, no. 1, pp. 39-58, 2020.
, “3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1487-1497, 2022.
, “Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.”, Nature, vol. 467, no. 7311, pp. 95-8, 2010.
, “Social isolation, loneliness, genetic risk, and incident dementia in people with type 2 diabetes mellitus: A population-based cohort study.”, J Alzheimers Dis, p. 13872877251344253, 2025.
,